CN105168758A - Medicine for treating hyperostosis - Google Patents
Medicine for treating hyperostosis Download PDFInfo
- Publication number
- CN105168758A CN105168758A CN201510735093.7A CN201510735093A CN105168758A CN 105168758 A CN105168758 A CN 105168758A CN 201510735093 A CN201510735093 A CN 201510735093A CN 105168758 A CN105168758 A CN 105168758A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- kidney
- radix angelicae
- hyperosteogeny
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicine for treating hyperostosis. The medicine is prepared from the following raw medicinal materials in parts by weight: 10 parts of eucommia bark, 6 parts of pyrola herb, 12 parts of root of doubleteeth pubescent angelica, 13 parts of east Asian tree fern rhizome, 10 parts of Chinese angelica, 9 parts of Chinese yam, 11 parts of barbary wolfberry fruit and 7 parts of medicinal cyathula root. The medicine provided by the invention makes use of the eucommia bark for nourishing liver and kidney and strengthening bones and muscles, the pyrola herb for eliminating dampness to strengthen tendons, the doubleteeth pubescent angelica for expelling wind-damp and treating arthralgia syndrome to stop pain, the east Asian tree fern rhizome for nourishing liver and kidney and expelling wind-damp, the Chinese angelica for nourishing blood and activating blood circulation, the Chinese yam for nourishing kidney and arresting seminal emission, the barbary wolfberry fruit for nourishing liver and kidney, and the medicinal cyathula root for easing joint movement. All the medicinal materials are used together to achieve effects of recuperating the kidney yang, dispelling cold and dampness, and relieving rigidity of muscles and joints, thereby effectively treating the hyperostosis. A clinical experiment proves that the medicine provided by the invention can be used for treating the hyperostosis safely and effectively.
Description
Technical field
The present invention relates to a kind of Chinese medicine, be specifically related to a kind of medicine being used for the treatment of hyperosteogeny.
Background technology
Hypertrophic osteoarthritis refers to due to degeneration of joint, so that the chronic joint disease that articular cartilage is destroyed and causes.Also known as hyperosteogeny, osteoarthritis, osteoarthritis and hypertrophiarthritis etc.
Primary disease onset is slow, without General Symptoms, mostly is the person in middle and old age of more than 50 years old.Be often multi-joint morbidity, also have simple joint to send out patient.Affected joints can have persistence dull pain, increases the weight of during movable increase, takes a turn for the better after having a rest.Pain is often not serious, increases the weight of when air pressure reduces, relevant with climate change.Sometimes can there is acute pain episodes, have joint stiff sense simultaneously, can find that intraarticular has crunch once in a while.Sitting posterior joint is stiff to be increased the weight of, and take a turn for the better after slightly movable, someone is referred to as " rest pain ".Later stage arthroncus, increase and limitation of movement, little complete tetanus, generally shows as bone retardance and levies.
Current doctor trained in Western medicine there is no effective way to this disease.Multiplex analgesic and vitamin agent.Severe patient takes operative treatment.
Medical material involved in the present invention is recorded in all as seen " China's book on Chinese herbal medicine ".
Summary of the invention
The present invention aims to provide a kind of medicine being used for the treatment of hyperosteogeny, by selecting suitable medical material and proportioning thereof, reaches the object of safe and effective healing hyperosteogeny.
In order to achieve the above object, the present invention is by the following technical solutions:
Be used for the treatment of a medicine for hyperosteogeny, it is characterized in that, it is prepared from by the raw medicinal material of following weight proportion: the Cortex Eucommiae 10 parts, Herba Pyrolae 6 parts, Radix Angelicae Pubescentis 12 parts, Rhizoma Cibotii 13 parts, Radix Angelicae Sinensis 10 parts, Rhizoma Dioscoreae 9 parts, Fructus Lycii 11 parts, Radix Cyathulae 7 parts.
Inventor thinks: kidney store essential substances improving inspiration by invigorating kidney-QI, closes bone at body, the raw marrow of main bone.Long-term kidney weakness in addition damp wind and cold intrusion causes sclerotin degradation, causes pathological changes.Should based on kidney-replenishing dispelling cold and dampness relieving rigidity of muscles and joints in treatment.
The present invention uses: Cortex Eucommiae tonifying liver and kidney and strengthening bones and muscles; The strong muscle of Herba Pyrolae damp eliminating; Radix Angelicae Pubescentis expelling wind and dampness, numbness relieving and pain relieving; Rhizoma Cibotii invigorating the liver and kidney wind-damp dispelling; Chinese angelica blood supplementing is invigorated blood circulation; Rhizoma Dioscoreae the kidney invigorating arresting seminal emission; Fructus Lycii nourishing the liver and kidney; Radix Cyathulae easing joint movement.All medicines share, and play effect of kidney-replenishing dispelling cold and dampness relieving rigidity of muscles and joints altogether, effectively treat hyperosteogeny.
Below in conjunction with clinical laboratory data, beneficial effect of the present invention is described:
1, physical data
Inventor collects hyperosteogeny patient 80 example for 2012 altogether between year December of December ~ 2014, all carry out Orthopaedics Clinic, 50 ~ 70 years old age, male 40 example, women 40 example.The course of disease 1 year ~ 5 years.
Diagnostic criteria: 1. pain, lifting in morning, alleviates after activity.After multi-activity heavy burden, pain increases the weight of again, swollen based on acid, uncomfortable.2. many without obvious pressure pain point.3. limitation of activity.4. pain portion knocking has comfort sense.5. nerve compression sign is not accompanied.6. x line sheet display vertebral body has osteophytosis.
Exclusion standard: trimester of pregnancy, women breast-feeding their children; Merge serious cardiopulmonary hepatorenal disease person.
2, test method
The decoct that the oral the present invention of all patients obtains according to embodiment 1, every day 3 times.8 weeks courses for the treatment of.
3, criterion of therapeutical effect and therapeutic outcome
3.1 criterion of therapeutical effect
Judge according to " hyperosteogeny diagnosis and efficacy assessment standard ".
1. cure: pain disappears and do not affect work or physical labor;
2. take a turn for the better: pain slightly alleviates, work work is slightly affected;
3. invalid: Clinical symptom and sign is without improvement.。
3.2 therapeutic outcome
80 routine patients cure 52 examples, effective 22 examples, invalid 6 examples, total effective rate 92.5%.There is laxativeness in treatments period 2 example, has no other obvious adverse reaction.It is safe and effective that visible the present invention is used for the treatment of hyperosteogeny, has the value applied.
Detailed description of the invention
In order to understand better and implement the present invention, further illustrate the present invention below in conjunction with specific embodiment.
Embodiment 1
Take: the Cortex Eucommiae 10 grams, Herba Pyrolae 6 grams, Radix Angelicae Pubescentis 12 grams, Rhizoma Cibotii 13 grams, Radix Angelicae Sinensis 10 grams, Rhizoma Dioscoreae 9 grams, Fructus Lycii 11 grams, Radix Cyathulae 7 grams; Add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, is concentrated into 120 grams, must meet the decoct of adult normal's one day consumption.
Be used for the treatment of hyperosteogeny.Oral, every bu morning, noon and afternoon take for three times.
Embodiment 2
Take: the Cortex Eucommiae 10 grams, Herba Pyrolae 6 grams, Radix Angelicae Pubescentis 12 grams, Rhizoma Cibotii 13 grams, Radix Angelicae Sinensis 10 grams, Rhizoma Dioscoreae 9 grams, Fructus Lycii 11 grams, Radix Cyathulae 7 grams; Add 10 times of water gagings, decoct 2 hours, filter; Filtering residue adds 8 times of water gagings, decocts 1.5 hours, filters; Merging filtrate, concentrated, dry, packaging, must meet the powder of adult normal's one day consumption.
Be used for the treatment of hyperosteogeny.Oral, daily once.
Embodiment 3
Take: the Cortex Eucommiae 10 grams, Herba Pyrolae 6 grams, Radix Angelicae Pubescentis 12 grams, Rhizoma Cibotii 13 grams, Radix Angelicae Sinensis 10 grams, Rhizoma Dioscoreae 9 grams, Fructus Lycii 11 grams, Radix Cyathulae 7 grams; Add 6 times of water gagings, decoct 3 times, each decoction 1 hour, merges decoction liquor, concentrated, dry, incapsulates shell, must meet the capsule of adult normal's one day consumption.
Be used for the treatment of hyperosteogeny.Oral, every bu is taken for twice sooner or later.
Claims (4)
1. one kind is used for the treatment of the medicine of hyperosteogeny, it is characterized in that, it is prepared from by the raw medicinal material of following weight proportion: the Cortex Eucommiae 10 parts, Herba Pyrolae 6 parts, Radix Angelicae Pubescentis 12 parts, Rhizoma Cibotii 13 parts, Radix Angelicae Sinensis 10 parts, Rhizoma Dioscoreae 9 parts, Fructus Lycii 11 parts, Radix Cyathulae 7 parts.
2. be used for the treatment of the medicine of hyperosteogeny as claimed in claim 1, it is characterized in that, its preparation method is: take: the Cortex Eucommiae 10 parts, Herba Pyrolae 6 parts, Radix Angelicae Pubescentis 12 parts, Rhizoma Cibotii 13 parts, Radix Angelicae Sinensis 10 parts, Rhizoma Dioscoreae 9 parts, Fructus Lycii 11 parts, Radix Cyathulae 7 parts; Add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, is concentrated into 120 parts, obtains decoct; Above-mentioned part all refers to weight portion.
3. be used for the treatment of the medicine of hyperosteogeny as claimed in claim 1, it is characterized in that, its preparation method is: take: the Cortex Eucommiae 10 parts, Herba Pyrolae 6 parts, Radix Angelicae Pubescentis 12 parts, Rhizoma Cibotii 13 parts, Radix Angelicae Sinensis 10 parts, Rhizoma Dioscoreae 9 parts, Fructus Lycii 11 parts, Radix Cyathulae 7 parts; Add 10 times of water gagings, decoct 2 hours, filter; Filtering residue adds 8 times of water gagings, decocts 1.5 hours, filters; Merging filtrate, concentrated, dry, packaging, obtains powder; Above-mentioned part all refers to weight portion.
4. be used for the treatment of the medicine of hyperosteogeny as claimed in claim 1, it is characterized in that, its preparation method is: take: the Cortex Eucommiae 10 parts, Herba Pyrolae 6 parts, Radix Angelicae Pubescentis 12 parts, Rhizoma Cibotii 13 parts, Radix Angelicae Sinensis 10 parts, Rhizoma Dioscoreae 9 parts, Fructus Lycii 11 parts, Radix Cyathulae 7 parts; Add 6 times of water gagings, decoct 3 times, each decoction 1 hour, merges decoction liquor, concentrated, dry, incapsulates shell, obtains capsule; Above-mentioned part all refers to weight portion.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510735093.7A CN105168758A (en) | 2015-11-03 | 2015-11-03 | Medicine for treating hyperostosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510735093.7A CN105168758A (en) | 2015-11-03 | 2015-11-03 | Medicine for treating hyperostosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105168758A true CN105168758A (en) | 2015-12-23 |
Family
ID=54891508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510735093.7A Pending CN105168758A (en) | 2015-11-03 | 2015-11-03 | Medicine for treating hyperostosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105168758A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1150910A (en) * | 1996-04-18 | 1997-06-04 | 花茂时 | Osteophytosis pill and its compounding method |
| CN1872310A (en) * | 2006-04-21 | 2006-12-06 | 张岚 | Preparation of Chinese traditional medicine for treating hyperosteogeny |
| CN101703662A (en) * | 2009-11-13 | 2010-05-12 | 秦中文 | Oral Chinese medicament for treating hyperosteogeny |
| CN103860760A (en) * | 2012-12-17 | 2014-06-18 | 青岛信立德中药技术研究开发有限公司 | Traditional Chinese medicine composition used for treating hyperosteogeny |
-
2015
- 2015-11-03 CN CN201510735093.7A patent/CN105168758A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1150910A (en) * | 1996-04-18 | 1997-06-04 | 花茂时 | Osteophytosis pill and its compounding method |
| CN1872310A (en) * | 2006-04-21 | 2006-12-06 | 张岚 | Preparation of Chinese traditional medicine for treating hyperosteogeny |
| CN101703662A (en) * | 2009-11-13 | 2010-05-12 | 秦中文 | Oral Chinese medicament for treating hyperosteogeny |
| CN103860760A (en) * | 2012-12-17 | 2014-06-18 | 青岛信立德中药技术研究开发有限公司 | Traditional Chinese medicine composition used for treating hyperosteogeny |
Non-Patent Citations (1)
| Title |
|---|
| 刘乡: ""骨质增生中医药治疗概况"", 《甘肃中医学院学报》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104940810A (en) | Traditional Chinese medicine composition for treating angina | |
| CN101623409B (en) | Traditional Chinese medicine preparation for treating apoplexy | |
| CN104587186A (en) | Traditional Chinese medicinal composition for treating qi and blood deficiency | |
| CN104606561A (en) | Traditional Chinese medicinal composition for treating spontaneous perspiration | |
| CN101554470A (en) | Traditional Chinese medicine for treating tachycardia | |
| CN103301411A (en) | Traditional Chinese medicine wine for treating soft tissue injury and preparation method thereof | |
| CN102430030B (en) | Chinese medicinal composition for treating bone impediment | |
| CN102961561B (en) | Chinese medicinal composition for treating coronary heart disease | |
| CN105168758A (en) | Medicine for treating hyperostosis | |
| CN104117018A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN103212041A (en) | Chinese medicinal composition treating coronary heart disease | |
| CN104027451B (en) | A kind of Chinese medicine for the treatment of deficiency of the liver and kindey pattern of syndrome sciatica | |
| CN102872287A (en) | Traditional Chinese medicine composition for treating femoral head necrosis and preparation method thereof | |
| CN103316226B (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN104056196A (en) | Traditional Chinese medicine composition for treating bradycardia | |
| CN105287753A (en) | Traditional Chinese medicine composition for treating multiple sclerosis | |
| CN105106786A (en) | Traditional Chinese medicine composition capable of dredging collaterals and relaxing muscles as well as preparation and production method of composition | |
| CN103550689B (en) | A kind of Chinese medicine composition for the treatment of the thoracic obstruction | |
| CN104435883A (en) | Traditional Chinese medicine preparation for treating calcaneodynia | |
| CN104547989A (en) | Tibetan paste for treating spondylodynia and using method thereof | |
| CN104107266A (en) | Bone-strengthening tablet | |
| CN101843718A (en) | Chinese medicament for treating lupus erythematosus | |
| CN101843705A (en) | Chinese medicament for treating lupus erythematosus | |
| CN107823369A (en) | The easypro neck of bone living dissipates | |
| CN107693639A (en) | A kind of Chinese medicine preparation and preparation method for treating ankylosing spondylitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151223 |